4.7 Article

3D nanoporous hybrid nanoflower for enhanced non-faradaic redox-free electrochemical impedimetric biodetermination

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.jtice.2020.11.006

Keywords

Non-faradaic impedance; Glutaraldehyde; Hybrid nanoflower; Tuberculosis

Funding

  1. Universiti Teknologi Petronas (UTP)
  2. Lloyd's Register Foundation-International Consortium of Nanotechnology [LRF ICON 015ME0-049]
  3. Universiti Malaysia Perlis [9001-00596]
  4. Sao Paulo Research Foundation-FAPESP [2014/23546-1, 2016/23474-6]
  5. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [16/23474-6] Funding Source: FAPESP

Ask authors/readers for more resources

Recently, non-faradaic electrochemical impedimetric (nfEIS) has been identified as a dynamic and robust method for bio-determining. However, the success of a nfEIS approach largely depends on its sensing layer architecture. In this study, the use of a Glutaraldehyde (GA) crosslinked copper (Cu) - bovine serum albumin (BSA) hybrid nanoflower with three-dimensional nanoporous architecture for the sensing layer was investigated. The nanoflower morphology changes were observed under FESEM, revealing loosely interlaced nanoflower into a tightly interlaced, highly porous structure upon GA crosslinking. This nanoflower was hybridized to immobilize aminated-DNA probe on the transducer surface and detect the target TB DNA in their natural redox-free environment. FTIR and XPS characterization showed distinct peaks at 950-1100 cm(-1) (P-O, P=O bonds from nanoflower and DNA backbone) and 286.48 eV (interaction between BSA and aminated DNA), respectively, validating the successful DNA probe immobilization on the nanoflower surface. Furthermore, impedimetric sensing in a redox-free environment showed that the developed TB biosensor present has a detection limit (LOD) of 60 pM with a (linear) range from 1 pM to 1 mu M with good reproducibility. This redox-free non-faradaic EIS offers excellent biosensing potential and may be extended for diagnos ing other biomarkers in clinical practice. (c) 2020 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available